Zobrazeno 1 - 10
of 606
pro vyhledávání: '"59"'
Autor:
Francis Bauters, Brigitte Dupriez, Pierre Fenaux, Jean-Pierre Jouet, Pierre Morel, Bernard Gosselin, Thierry Facon, Marie-Hélène Estienne
Publikováno v:
Cancer. 71:207-215
The outcomes were analyzed retrospectively of 59 cases of non-Hodgkin lymphoma (NHL) that included prominent splenic involvement (LPS). Forty-three patients had low-grade NHL, and 16 had intermediate or high-grade NHL. Forty of the 59 patients underw
Autor:
Yukunori Korogi, Katsuya Yahara, Hajime Imada, Shinsaku Yamaguchi, Takayuki Ohguri, Hiromi Terashima, Seung Dae Moon
Publikováno v:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 27(1)
To assess the relationship between the radiofrequency (RF) output power and the intra-oesophageal temperature for hyperthermia of the whole thoracic region, and also to evaluate the patients' characteristics associated with adequate heating.Fifty-nin
Autor:
Yasuhiko Kano, Yusuke Furukawa, Susumu Katano, Keiya Ozawa, Takahiro Nagashima, Masanori Fukushima, Koichi Inoue, Hiroyuki Kobayashi, Keita Kirito, Seiji Igarashi, Kaoru Hirabayashi, Masaru Tanaka, Satoshi Teramukai, Ken Ohmine, Kazuya Sato, Tohru Izumi, Miyuki Akutsu, Saburo Tsunoda
Publikováno v:
Scopus-Elsevier
We evaluated the long-term outcome of very dose-intensive chemotherapy (TCC-NHL-91) for advanced intermediate-grade lymphoma, in which an eight-cycle regimen with 11 drugs was given with granulocyte colony-stimulating factor (G-CSF) support (total 18
Publikováno v:
International journal of radiation oncology, biology, physics. 107(3)
Purpose To evaluate the efficacy and safety of postoperative concurrent chemoradiation therapy using weekly docetaxel in patients with high-risk oral squamous cell carcinoma (OSCC). Methods and Materials This is a prospective single-arm study from a
Autor:
Eric P. van der Stok, Cornelis J. A. Punt, Leonie J. M. Mekenkamp, Cornelis Verhoef, Bastiaan Wiering, Miriam Koopman, Jannemarie A. M. de Ridder, Johannes H. W. de Wilt
Publikováno v:
European Journal of Cancer, 59, 13-21. Elsevier Ltd.
European Journal of Cancer, 59, 13-21
European journal of cancer (Oxford, England, 59, 13-21. Elsevier Limited
European Journal of Cancer, 59, 13. Elsevier Limited
European Journal of Cancer, 59, pp. 13-21
European Journal of Cancer, 59, 13-21
European journal of cancer (Oxford, England, 59, 13-21. Elsevier Limited
European Journal of Cancer, 59, 13. Elsevier Limited
European Journal of Cancer, 59, pp. 13-21
Item does not contain fulltext OBJECTIVE: To evaluate and compare the overall survival (OS) in case-matched patient groups treated either with systemic therapy or surgery for colorectal liver metastases (CRLM). METHODS: Patients with CRLM, without ex
Autor:
Ivana Gojo, Leo Luznik, B. Douglas Smith, Shannon R. McCurdy, Ephraim J. Fuchs, William Matsui, Douglas E. Gladstone, Margaret M. Showel, Yvette L. Kasamon, Hua Ling Tsai, Lode J. Swinnen, Michael A. McDevitt, Gabrielle T. Prince, Gary L. Rosner, Keith W. Pratz, Richard J. Jones, Amy E. DeZern, Jennifer A. Kanakry, Richard F. Ambinder, Mark J. Levis, Karlo Perica, Satish Shanbhag, Javier Bolaños-Meade, Ivan Borrello, Robert A. Brodsky, Carol Ann Huff
Publikováno v:
Journal of Clinical Oncology. 33:3152-3161
Purpose Recent advances in nonmyeloablative (NMA), related HLA-haploidentical blood or marrow transplantation (haplo-BMT) have expanded the donor pool. This study evaluated the effect of age on NMA haplo-BMT outcomes in patients age 50 to 75 years. P
Autor:
Rasmus Heje Thomsen, Jette Sønderskov Gørløv, Søren Ramme Nielsen, Charlotte Madsen, Susanne Oksbjerg Dalton, Kristina Fruerlund Nielsen, Peter de Nully Brown, Maja Halgren Olsen, Bente Arboe, Anne Katrine Duun-Henriksen
Publikováno v:
Arboe, B, Halgren Olsen, M, Duun-Henriksen, A K, Gørløv, J S, Nielsen, K F, Thomsen, R H, Madsen, C, Ramme Nielsen, S, Dalton, S O & Brown, P D N 2018, ' Prolonged hospitalization, primary refractory disease, performance status and age are prognostic factors for survival in patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation ', Leukemia and Lymphoma, vol. 59, no. 5, pp. 1153-1162 . https://doi.org/10.1080/10428194.2017.1369061
Arboe, B, Halgren Olsen, M, Duun-Henriksen, A K, Gørløv, J S, Nielsen, K F, Thomsen, R H, Madsen, C, Nielsen, S R, Dalton, S O & Brown, P D N 2018, ' Prolonged hospitalization, primary refractory disease, performance status and age are prognostic factors for survival in patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation ', Leukemia and Lymphoma, vol. 59, no. 5, pp. 1153-1162 . https://doi.org/10.1080/10428194.2017.1369061
Arboe, B, Halgren Olsen, M, Duun-Henriksen, A K, Gørløv, J S, Nielsen, K F, Thomsen, R H, Madsen, C, Nielsen, S R, Dalton, S O & Brown, P D N 2018, ' Prolonged hospitalization, primary refractory disease, performance status and age are prognostic factors for survival in patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation ', Leukemia and Lymphoma, vol. 59, no. 5, pp. 1153-1162 . https://doi.org/10.1080/10428194.2017.1369061
In patients with relapsed diffuse large B-cell lymphoma (DLBCL), high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is standard treatment. Here, we aim to identify factors associated with survival in patients undergoing AS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1740139ca7428f6006413c145c81abc
https://portal.findresearcher.sdu.dk/da/publications/1af97bf7-5eb6-4557-a706-f2b00777ae55
https://portal.findresearcher.sdu.dk/da/publications/1af97bf7-5eb6-4557-a706-f2b00777ae55
Autor:
Steven Pi, Adam Bryant, Alok P. Vakil, Yasser Abou Mourad, Jason Pal, Soo Yeon Lee, Areej Al Mugairi, Sally C Lau, Nikisha S. Khare, Bakul I. Dalal
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 14:239-244
The standard-risk (SR) subgroup of acute lymphoblastic leukemia in adults (aALL) is a heterogeneous category, with a 20% to 40% relapse rate and a wide range of relapse-free survival (RFS) and overall survival (OS). There is a need to identify at the
Publikováno v:
International journal of radiation oncology, biology, physics. 98(4)
Purpose To compare patterns of care for elderly patients aged ≥70 years with locally advanced head and neck cancer versus those of younger patients treated for the same disease. Methods and Materials The medical records of 421 consecutive patients
Autor:
Xingpeng Han, Yin Li, Jian Hu, Yang Liu, Xiangning Fu, Xin Peng, Xiaofei Li, Tianyu He, Lunxu Liu, Heng Zhao, Yihe Wu, Jinming Xu, Deruo Liu, Lin Xu, Jinlin Cao
Publikováno v:
Clinical Lung Cancer. 23:170-176
Background Video-assisted thoracic surgery (VATS) has been widely used in the surgical treatment of thoracic diseases, and it suggested surgical and oncological advantages compared with open surgery. However, reports on the application of VATS in sur